Health Ranger Report: Dr. William Makis reveals CANCER PROTOCOLS suppressed by Big Pharma

• Patients and practitioners are increasingly turning to alternative treatments like CBD oil, vitamin E and fenbendazole, which have shown remarkable results in shrinking tumors and even curing terminal cancers, despite being dismissed by mainstream medicine.
• Fenbendazole gained attention after Joe Tippens, a terminal cancer patient, achieved remission by combining it with curcumin, CBD oil and vitamin E. Over 110,000 members in the Fenbendazole Cancer Support Group and documented cases of remission highlight its potential, yet it remains unapproved for human cancer treatment.
• Originally an antiparasitic drug, ivermectin has demonstrated significant anticancer effects, with studies showing positive responses in 28 types of cancer. Despite its potential, pharmaceutical companies like Merck have distanced themselves from it, focusing instead on high-cost treatments like mRNA cancer vaccines.
• Natural treatments like CBD oil and vitamin E have shown efficacy in cancer treatment, but their lack of profitability and patentability has led to their suppression by the pharmaceutical industry. Doctors advocating for these treatments face professional repercussions, highlighting systemic resistance to affordable, accessible options.
• Dr. William Makis and others are advocating for a “great reset” in medicine, prioritizing ethical practices, scientific integrity and patient access to effective, affordable treatments. The movement seeks to dismantle a profit-driven system and empower patients with alternative, evidence-based options.

In the shadow of conventional cancer treatments like chemotherapy and radiation, a quiet revolution is unfolding. Patients and practitioners are turning to unconventional yet shockingly effective protocols involving CBD oil, vitamin E and fenbendazole – a deworming medication for animals.

These treatments, often dismissed or suppressed by mainstream medicine, are delivering remarkable results, from shrinking tumors to eradicating terminal cancers. But why aren’t these life-saving protocols widely known? The answer lies in the profit-driven machinery of Big Pharma and the systemic suppression of affordable, accessible treatments.

Dr. William Makis, a radiologist, oncologist and cancer researcher, has emerged as a leading voice in this underground movement. In a recent “Health Ranger Report” interview with Mike Adams on Brighteon.com, Makis shared compelling evidence and patient stories that challenge the status quo of cancer care.

The story of fenbendazole’s anticancer properties began in 2017 with Joe Tippens, a man diagnosed with terminal stage 4 small cell lung cancer. Sent home to die, Tippens was introduced to fenbendazole by a veterinarian friend who had heard of its potential anticancer effects. Combining fenbendazole with curcumin, CBD oil and vitamin E, Tippens defied the odds and cured his cancer. (Related: People claim to be curing pancreatic cancer with fenbendazole, a common veterinary medicine that kills parasites)

Since then, fenbendazole has gained traction among cancer patients, with over 110,000 members in the Fenbendazole Cancer Support Group on Facebook. Stanford University researchers even documented three cases of stage 4 cancer patients who, after failing all conventional treatments, achieved remission using fenbendazole. Yet, despite these successes, fenbendazole remains unapproved for human cancer treatment, while its nearly identical counterpart, mebendazole, is Food and Drug Administration (FDA)-approved but far more expensive.

Ivermectin has also shown remarkable potential in cancer treatment. Originally an antiparasitic, ivermectin has been studied extensively for its anticancer properties. Mexican researchers tested it against 28 different cancers and found that every single one responded to the drug, with ovarian, breast and prostate cancers showing the most significant results.

Makis highlighted a case where ivermectin put two children with aggressive leukemia into remission after chemotherapy had failed. Yet, like fenbendazole, ivermectin faces fierce opposition from pharmaceutical companies. Merck, the original patent holder of ivermectin, has distanced itself from the drug, focusing instead on a $500,000 mRNA cancer vaccine developed in partnership with Moderna.

Natural compounds like CBD oil and vitamin E are also proving to be powerful allies in the fight against cancer. Makis shared case reports of lung cancer lesions disappearing after months of CBD oil use and skin cancers falling off with topical application. Vitamin E, when combined with fenbendazole, has shown a synergistic effect, enhancing tumor shrinkage in preclinical studies.

Makis: There’s no money in actually curing cancer

Despite the growing body of evidence supporting these treatments, they remain largely ignored by mainstream medicine. Makis attributes this to the lack of profitability for pharmaceutical companies, telling Adams that “there’s no money in certain cures.” The renowned Canadian physician cited CBD oil as an example; it costs between $50 and $100, and it is not patentable.

But suppression of these treatments extends beyond corporate greed. Doctors who advocate for repurposed drugs like ivermectin and fenbendazole face severe repercussions, including loss of medical licenses and board certifications. Makis himself operates outside the traditional medical system, offering health coaching to cancer patients who seek alternative treatments.

The fight for health freedom is far from over. Makis and others are calling for a “great reset” in medicine – one that prioritizes ethical practices, scientific integrity and patient access to affordable treatments. “We need to disassemble the entire corrupt system,” Makis said.

AntiCancer.news has more stories like this.

Watch the video below to know more about the interview of Dr. William Makis with Mike Adams.

This video is from the Health Ranger Report channel on Brighteon.com.

More related stories:

World’s first peer-reviewed study on anticancer benefits of ivermectin, mebendazole and fenbendazole published in reputable journal.

Ivermectin outperforms chemo in breast cancer treatment, study finds.

Synergistic pairing of ivermectin and fenbendazole found HIGHLY EFFECTIVE at preventing and treating cancer.

Sources include:

Brighteon.com

William-Makis.com